Tshiab US Patent rau Kev Tshawb Fawb PTSD hauv Cov Ntsiab Lus Nyob

Tsab ntawv patent, hu ua "Cov Txheej Txheem thiab Cov Txheej Txheem txhawm rau txheeb xyuas GluA1 hauv hlwb thiab txhawm rau txheeb xyuas qhov muaj GluA1-Mediated PTSD," yog qhia rau cov ntawv sau tshiab thiab cov txheej txheem rau kev kuaj mob PTSD nrog rau kev kho PTSD tom qab kuaj pom zoo li no.              

“The compound protected by this patent is from one of a series of classes that Neurovation Labs is developing to enable objective diagnosis of PTSD and to better evaluate the mechanisms underlying PTSD and other mental health disorders. These compounds and the corresponding methods covered by the patent represent a novel, targeted approach to mental health and visualizing brain-mediated disorders,” said Dr. Jennifer Perusini, Co-Founder & Chief Executive Officer of the .

Cov patent no yog tus tswv los ntawm Neurovation Labs nkaus xwb thiab yog thawj qhov kev tshaj tawm los ntawm cov cuab yeej cuab tam dav dav los ntawm lub tuam txhab kev tshawb fawb thiab kev tsim kho.

Print Friendly, PDF & Email
Tsis muaj tus cim npe rau tshaj tawm no.